Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Forecast: What Value Will The Market Reach By 2030?#_x000D_
The chronic obstructive pulmonary disease (copd) and asthma devices market has shown substantial growth over recent years. This market is anticipated to expand from $47.56 billion in 2025 to $50.3 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.8%. The historical rise in this market can be attributed to the increasing prevalence of asthma and COPD, heightened air pollution and smoking rates, a growing reliance on inhalation therapy, the expansion of respiratory care services, and improvements in the diagnosis of chronic respiratory diseases._x000D_
_x000D_
The chronic obstructive pulmonary disease (copd) and asthma devices market is poised for substantial growth over the next few years. It is projected to expand to $62.83 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.7%. This anticipated expansion can be attributed to several factors, such as an aging population facing higher respiratory risks, an increasing need for home care respiratory equipment, heightened awareness regarding early management of respiratory conditions, the spread of chronic disease management initiatives, and improved access to respiratory care in emerging markets. Significant trends expected during this forecast period encompass the rising adoption of home-based respiratory care devices, a growing demand for portable and user-friendly inhalation devices, an intensified focus on long-term disease management solutions, an expansion of device utilization across pediatric and geriatric demographics, and an increased emphasis on treatment adherence and symptom control._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Growth Factors Behind Sustained Expansion#_x000D_
The increasing occurrence of respiratory conditions is projected to drive the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market in the future. These diseases cover numerous ailments impacting the lungs and respiratory systems, including asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, which hinder breathing and general respiratory function. The rising incidence of respiratory illnesses stems from heightened air pollution, shifting climate patterns influencing allergens and pathogens, and lifestyle choices like smoking that impair respiratory well-being. COPD and asthma devices are vital for the thorough management and treatment of these respiratory conditions, helping patients attain improved respiratory health and boost their overall quality of life. For example, data from December 2023, sourced from the National Center for Biotechnology Information, a US-based government agency, indicated that the count of COPD cases was anticipated to increase by 112 million, summing up to 592 million by 2050, constituting 9.5% of the eligible demographic. Consequently, the expanding occurrence of respiratory diseases fuels the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices markets._x000D_
_x000D_
#Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Segment Analysis: What Are The Core Market Categories?#_x000D_
The chronic obstructive pulmonary disease (copd) and asthma devices market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types_x000D_
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease_x000D_
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications_x000D_
4) By End User: Pediatric, Adult, Geriatric_x000D_
_x000D_
Subsegments:_x000D_
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI _x000D_
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI _x000D_
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices _x000D_
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers _x000D_
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers _x000D_
6) By Other Types: Nebulizer Accessories, Spacer Devices_x000D_
_x000D_
#Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Industry Trends Fueling Future Revenue Growth#_x000D_
Leading companies in the chronic obstructive pulmonary disease and asthma devices market are concentrating on developing innovative solutions, such as intelligent, sensor-enabled inhaler technologies. These advancements aim to enhance medication adherence, facilitate real-time symptom tracking, and support personalized management of respiratory diseases. Such smart inhaler technologies integrate embedded sensors and digital connectivity features to capture inhalation data, monitor patient usage patterns, and deliver actionable insights to both patients and clinicians. For example, in July 2023, Teva UK Ltd., a UK-based pharmaceutical company, introduced the GoResp Digihaler. This digitally connected inhaler is engineered to record inhalation parameters, provide real-time feedback, and foster improved disease control through data-driven patient engagement. The device contributes to better treatment outcomes by enabling remote monitoring, offering clinicians greater insight into patient adherence trends, and strengthening long-term disease management for individuals affected by chronic respiratory conditions._x000D_
_x000D_
#Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the chronic obstructive pulmonary disease (copd) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., Aerogen Ltd _x000D_
_x000D_
#View The Full Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report:#_x000D_
_x000D_
#Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Geographic Spread And Regional Opportunities#_x000D_
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2025. The regions covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.